Search details
1.
Systemic administration of IL-33 induces a population of circulating KLRG1hi type 2 innate lymphoid cells and inhibits type 1 innate immunity against multiple myeloma.
Immunol Cell Biol
; 99(1): 65-83, 2021 01.
Article
in English
| MEDLINE | ID: mdl-32748462
2.
IL-23 promotes the development of castration-resistant prostate cancer.
Immunol Cell Biol
; 96(9): 883-885, 2018 10.
Article
in English
| MEDLINE | ID: mdl-30194885
3.
Concomitant or delayed anti-TNF differentially impact on immune-related adverse events and antitumor efficacy after anti-CD40 therapy.
J Immunother Cancer
; 8(2)2020 11.
Article
in English
| MEDLINE | ID: mdl-33199513
4.
Chemotherapy followed by anti-CD137 mAb immunotherapy improves disease control in a mouse myeloma model.
JCI Insight
; 52019 06 13.
Article
in English
| MEDLINE | ID: mdl-31194697
5.
CD155 loss enhances tumor suppression via combined host and tumor-intrinsic mechanisms.
J Clin Invest
; 128(6): 2613-2625, 2018 06 01.
Article
in English
| MEDLINE | ID: mdl-29757192
6.
CD155 loss enhances tumor suppression via combined host and tumor-intrinsic mechanisms.
J Clin Invest
; 132(6)2022 03 15.
Article
in English
| MEDLINE | ID: mdl-35289314
7.
Anticancer immunotherapy by CTLA-4 blockade: obligatory contribution of IL-2 receptors and negative prognostic impact of soluble CD25.
Cell Res
; 25(2): 208-24, 2015 Feb.
Article
in English
| MEDLINE | ID: mdl-25582080
8.
Improved mouse models to assess tumour immunity and irAEs after combination cancer immunotherapies.
Clin Transl Immunology
; 3(8): e22, 2014 Aug.
Article
in English
| MEDLINE | ID: mdl-25505970
9.
Co-blockade of immune checkpoints and adenosine A2A receptor suppresses metastasis.
Oncoimmunology
; 3(10): e958952, 2014 Nov.
Article
in English
| MEDLINE | ID: mdl-25941583
10.
Differential potency of regulatory T cell-mediated immunosuppression in kidney tumors compared to subcutaneous tumors.
Oncoimmunology
; 3(11): e963395, 2014 Nov.
Article
in English
| MEDLINE | ID: mdl-25941590
11.
2018 Nobel Prize in physiology or medicine.
Clin Transl Immunology
; 7(10): e1041, 2018.
Article
in English
| MEDLINE | ID: mdl-30386598
12.
Erratum: anticancer immunotherapy by CTLA-4 blockade: obligatory contribution of IL-2 receptors and negative prognostic impact of soluble CD25.
Cell Res
; 25(3): 399-400, 2015 Mar.
Article
in English
| MEDLINE | ID: mdl-25732764
Results
1 -
12
de 12
1
Next >
>>